About
Sonata Therapeutics develops small molecule and genetic drugs that target the cellular microenvironment to treat oncology, fibrosis, and autoimmune diseases.
Explore Sonata Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.